Inventor · disambiguated record
Frank Bedu-Addo
Also filed as: BEDU-ADDO FRANK
13 granted patents·16 pending applications·141 citations·filing 2008–2024
92Inventor score
Top patents by PatentIndex Score
29 records- 0194US11801257B2Stimulation of an immune response by enantiomers of cationic lipidsPDS BIOTECHNOLOGY CORP·Filed 2020·Granted Oct 31, 2023·4 cites·13 claims
- 0294US10828364B2Method for reducing a myeloid derived suppressor cell population with cationic lipid vaccine compositionsPDS BIOTECHNOLOGY CORP·Filed 2019·Granted Nov 10, 2020·8 cites·19 claims
- 0392US11911465B2Vaccine compositions and methods of usePDS BIOTECHNOLOGY CORP·Filed 2021·Granted Feb 27, 2024·2 cites·12 claims
- 0492US10702541B2Stimulation of an immune response by enantiomers of cationic lipidsPDS BIOTECHNOLOGY CORP·Filed 2017·Granted Jul 7, 2020·7 cites·13 claims
- 0592US8877206B2Stimulation of an immune response by cationic lipidsCHEN WEIHSU·Filed 2008·Granted Nov 4, 2014·78 cites·44 claims
- 0691US12201685B2Methods of modulating immune responses with cationic lipid vaccine compositionsPDS BIOTECHNOLOGY CORP·Filed 2020·Granted Jan 21, 2025·2 cites·18 claims
- 0791US11401306B2HPV16 non HLA-restricted t-cell vaccines, compositions and methods of use thereofPDS BIOTECHNOLOGY CORP·Filed 2017·Granted Aug 2, 2022·9 cites·10 claims
- 0888US10286064B2Cationic lipid vaccine compositions and methods of usePDS BIOTECHNOLOGY CORP·Filed 2013·Granted May 14, 2019·9 cites·3 claims
- 0987US11904015B2Vaccine compositions and methods of usePDS BIOTECHNOLOGY CORP·Filed 2019·Granted Feb 20, 2024·2 cites·18 claims
- 1087US11638753B2Lipids as synthetic vectors to enhance antigen processing and presentation ex-vivo in dendritic cell therapyPDS BIOTECHNOLOGY CORP·Filed 2019·Granted May 2, 2023·4 cites·18 claims
- 1186US11612652B2Lipids as synthetic vectors to enhance antigen processing and presentation ex-vivo in dendritic cell therapyPDS BIOTECHNOLOGY CORP·Filed 2016·Granted Mar 28, 2023·4 cites·6 claims
- 1283US11911359B2Stimulation of an immune response by cationic lipidsPDS BIOTECHNOLOGY CORP·Filed 2014·Granted Feb 27, 2024·2 cites·21 claims
- 1383US9789129B2Stimulation of an immune response by enantiomers of cationic lipidsVASIEVICH ELIZABETH ANN·Filed 2009·Granted Oct 17, 2017·10 cites·4 claims
- 1477US2025018029A1Methods to alter the tumor microenvironment for effective cancer immunotherapyPDS BIOTECHNOLOGY CORP·Filed 2024·Application pending·0 cites
- 1572US2023285551A1Lipids as synthetic vectors to enhance antigen processing and presentation ex-vivo in dendritic cell therapyPDS BIOTECHNOLOGY CORP·Filed 2023·Application pending·0 cites
- 1672US2021346496A1Cationic lipid vaccine compositions and methods of usePDS BIOTECHNOLOGY CORP·Filed 2021·Application pending·0 cites
- 1771US2021346333A1Stimulation of an immune response by cationic lipidsPDS BIOTECHNOLOGY CORP·Filed 2021·Application pending·0 cites
- 1871US2022031650A1Stimulation of an immune response by cationic lipidsPDS BIOTECHNOLOGY CORP·Filed 2021·Application pending·0 cites
- 1969US2023052399A1Methods to alter the tumor microenvironment for effective cancer immunotherapyPDS BIOTECHNOLOGY CORP·Filed 2022·Application pending·0 cites
- 2069US2021308157A1Stimulation of an immune response by enantiomers of cationic lipidsPDS BIOTECHNOLOGY CORP·Filed 2021·Application pending·0 cites
- 2167US2022332768A1Novel hpv16 non hla-restricted t-cell vaccines, compositions and methods of use thereofPDS BIOTECHNOLOGY CORP·Filed 2022·Application pending·0 cites
- 2265US2024316178A1Recombinant protein vaccines formulated with enantio-specific cationic lipid r-dotap and methods of use thereofPDS BIOTECHNOLOGY CORP·Filed 2023·Application pending·0 cites
- 2365US2024317828A1T cell activating immunotherapeutic for treatment of mucin 1 protein expressing human cancersPDS BIOTECHNOLOGY CORP·Filed 2023·Application pending·0 cites
- 2465US2024317833A1Non-hla restricted t cell vaccine for tcr gamma alternate reading frame protein (tarp) protein expressing cancersPDS BIOTECHNOLOGY CORP·Filed 2023·Application pending·0 cites
- 2553US2015250872A1Vaccine compositions and methods of useBEDU-ADDO FRANK·Filed 2013·Application pending·0 cites
- 2653US2022160867A1Methods and compositions comprising cationic lipids for immunotherapy by direct tumor injectionPDS BIOTECHNOLOGY CORP·Filed 2021·Application pending·0 cites
- 2751US2019275145A1Particulate vaccine formulationsPDS BIOTECHNOLOGY CORP·Filed 2019·Application pending·0 cites
- 2849US2018221475A1Methods to alter the tumor microenvironment for effective cancer immunotherapyPDS BIOTECHNOLOGY CORP·Filed 2017·Application pending·0 cites
- 2946US2015110823A1Particulate vaccine formulationsBEDU-ADDO FRANK·Filed 2012·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Frank Bedu-Addo files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →